Merck & Co. Statistics
Total Valuation
Merck & Co. has a market cap or net worth of $373.48 billion. The enterprise value is $420.25 billion.
| Market Cap | 373.48B |
| Enterprise Value | 420.25B |
Important Dates
The last earnings date was Thursday, October 29, 2026, before market open.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | Sep 15, 2026 |
Share Statistics
Merck & Co. has 2.47 billion shares outstanding. The number of shares has decreased by -1.77% in one year.
| Current Share Class | 2.47B |
| Shares Outstanding | 2.47B |
| Shares Change (YoY) | -1.77% |
| Shares Change (QoQ) | +0.32% |
| Owned by Insiders (%) | 0.05% |
| Owned by Institutions (%) | 81.16% |
| Float | 2.46B |
Valuation Ratios
The trailing PE ratio is 153.10 and the forward PE ratio is 17.99. Merck & Co.'s PEG ratio is 4.05.
| PE Ratio | 153.10 |
| Forward PE | 17.99 |
| PS Ratio | 5.51 |
| Forward PS | 5.47 |
| PB Ratio | 8.85 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 23.09 |
| P/OCF Ratio | 18.58 |
| PEG Ratio | 4.05 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 26.17, with an EV/FCF ratio of 26.01.
| EV / Earnings | 170.30 |
| EV / Sales | 6.20 |
| EV / EBITDA | 26.17 |
| EV / EBIT | 41.19 |
| EV / FCF | 26.01 |
Financial Position
The company has a current ratio of 1.32, with a Debt / Equity ratio of 1.28.
| Current Ratio | 1.32 |
| Quick Ratio | 0.74 |
| Debt / Equity | 1.28 |
| Debt / EBITDA | 3.29 |
| Debt / FCF | 3.36 |
| Interest Coverage | 5.17 |
Financial Efficiency
Return on equity (ROE) is 6.96% and return on invested capital (ROIC) is 5.88%.
| Return on Equity (ROE) | 6.96% |
| Return on Assets (ROA) | 11.87% |
| Return on Invested Capital (ROIC) | 5.88% |
| Return on Capital Employed (ROCE) | 23.01% |
| Weighted Average Cost of Capital (WACC) | 4.52% |
| Revenue Per Employee | $898,373 |
| Profits Per Employee | $32,707 |
| Employee Count | 75,000 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 2.51 |
Taxes
In the past 12 months, Merck & Co. has paid $2.31 billion in taxes.
| Income Tax | 2.31B |
| Effective Tax Rate | 48.57% |
Stock Price Statistics
The stock price has increased by +80.83% in the last 52 weeks. The beta is 0.12, so Merck & Co.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.12 |
| 52-Week Price Change | +80.83% |
| 50-Day Moving Average | 146.51 |
| 200-Day Moving Average | 127.48 |
| Relative Strength Index (RSI) | 58.22 |
| Average Volume (20 Days) | 10,093,727 |
Short Selling Information
The latest short interest is 26.83 million, so 1.09% of the outstanding shares have been sold short.
| Short Interest | 26.83M |
| Short Previous Month | 34.43M |
| Short % of Shares Out | 1.09% |
| Short % of Float | 1.09% |
| Short Ratio (days to cover) | 2.68 |
Income Statement
In the last 12 months, Merck & Co. had revenue of $67.38 billion and earned $2.45 billion in profits. Earnings per share was $0.99.
| Revenue | 67.38B |
| Gross Profit | 51.82B |
| Operating Income | 10.14B |
| Pretax Income | 4.76B |
| Net Income | 2.45B |
| EBITDA | 15.96B |
| EBIT | 10.14B |
| Earnings Per Share (EPS) | $0.99 |
Balance Sheet
The company has $7.14 billion in cash and $53.91 billion in debt, with a net cash position of -$46.77 billion or -$18.96 per share.
| Cash & Cash Equivalents | 7.14B |
| Total Debt | 53.91B |
| Net Cash | -46.77B |
| Net Cash Per Share | -$18.96 |
| Equity (Book Value) | 41.98B |
| Book Value Per Share | 16.99 |
| Working Capital | 8.95B |
Cash Flow
In the last 12 months, operating cash flow was $19.97 billion and capital expenditures -$3.90 billion, giving a free cash flow of $16.06 billion.
| Operating Cash Flow | 19.97B |
| Capital Expenditures | -3.90B |
| Depreciation & Amortization | 5.82B |
| Net Borrowing | 18.69B |
| Free Cash Flow | 16.06B |
| FCF Per Share | $6.51 |
Margins
Gross margin is 76.91%, with operating and profit margins of 15.05% and 3.64%.
| Gross Margin | 76.91% |
| Operating Margin | 15.05% |
| Pretax Margin | 7.07% |
| Profit Margin | 3.64% |
| EBITDA Margin | 23.69% |
| EBIT Margin | 15.05% |
| FCF Margin | 24.13% |
Dividends & Yields
This stock pays an annual dividend of $3.40, which amounts to a dividend yield of 2.25%.
| Dividend Per Share | $3.40 |
| Dividend Yield | 2.25% |
| Dividend Growth (YoY) | 4.94% |
| Years of Dividend Growth | 15 |
| Payout Ratio | 343.87% |
| FCF Payout Ratio | 52.22% |
| Buyback Yield | 1.77% |
| Shareholder Yield | 4.03% |
| Earnings Yield | 0.65% |
| FCF Yield | 4.33% |
Analyst Forecast
The average price target for Merck & Co. is $161.53, which is 6.71% higher than the current price. The consensus rating is "Buy".
| Price Target | $161.53 |
| Price Target Difference | 6.71% |
| Analyst Consensus | Buy |
| Analyst Count | 28 |
| Revenue Growth Forecast (3Y) | 4.29% |
| EPS Growth Forecast (3Y) | 3.42% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on February 17, 1999. It was a forward split with a ratio of 2:1.
| Last Split Date | Feb 17, 1999 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |